Show simple item record

10.547J / 7.547J / 15.136J / HST.920J Principles and Practice of Drug Development, Fall 2005

dc.contributor.authorCooney, Charlesen_US
dc.contributor.authorRubin, Roberten_US
dc.contributor.authorFinkelstein MD, Stanen_US
dc.contributor.authorAllen, Tomen_US
dc.contributor.authorSinskey, Anthonyen_US
dc.coverage.temporalFall 2005en_US
dc.date.issued2005-12
dc.identifier10.547J-Fall2005
dc.identifierlocal: 10.547J
dc.identifierlocal: 7.547J
dc.identifierlocal: 15.136J
dc.identifierlocal: HST.920J
dc.identifierlocal: IMSCP-MD5-4a81249292a8f40bb3d6c29e776bb236
dc.identifier.urihttp://hdl.handle.net/1721.1/97101
dc.description.abstractThis course serves as a description and critical assessment of the major issues and stages of developing a pharmaceutical or biopharmaceutical. Topics covered include drug discovery, preclinical development, clinical investigation, manufacturing and regulatory issues considered for small and large molecules, and economic and financial considerations of the drug development process. A multidisciplinary perspective is provided by the faculty, who represent clinical, life, and management sciences. Various industry guests also participate.en_US
dc.languageen-USen_US
dc.relationen_US
dc.rights.uriUsage Restrictions: This site (c) Massachusetts Institute of Technology 2015. Content within individual courses is (c) by the individual authors unless otherwise noted. The Massachusetts Institute of Technology is providing this Work (as defined below) under the terms of this Creative Commons public license ("CCPL" or "license") unless otherwise noted. The Work is protected by copyright and/or other applicable law. Any use of the work other than as authorized under this license is prohibited. By exercising any of the rights to the Work provided here, You (as defined below) accept and agree to be bound by the terms of this license. The Licensor, the Massachusetts Institute of Technology, grants You the rights contained here in consideration of Your acceptance of such terms and conditions.en_US
dc.rights.uriUsage Restrictions: Attribution-NonCommercial-ShareAlike 3.0 Unporteden_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.subjectpharmaceuticalen_US
dc.subjectbiopharmaceuticalen_US
dc.subjectdrug discoveryen_US
dc.subjectpreclinical developmenten_US
dc.subjectclinical investigationen_US
dc.subjectmajor issues of developing drugsen_US
dc.subjectmajor stages of developing drugsen_US
dc.subjectmanufacturing issuesen_US
dc.subjectregulatory issuesen_US
dc.subjecteconomic considerations of drug development processen_US
dc.subjectfinancial considerations of drug development processen_US
dc.subjectclinical perspectiveen_US
dc.subjectlife sciences perspective on drug developmenten_US
dc.subjectmanagement sciences perspective on drug developmenten_US
dc.subjectpharmaceutical industry guestsen_US
dc.title10.547J / 7.547J / 15.136J / HST.920J Principles and Practice of Drug Development, Fall 2005en_US
dc.title.alternativePrinciples and Practice of Drug Developmenten_US
dc.typeLearning Object
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemical Engineering
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biology
dc.contributor.departmentHarvard University--MIT Division of Health Sciences and Technology
dc.contributor.departmentSloan School of Management


Files in this item

Thumbnail
Name:
10-547j-fall-2005/contents/ind ...
Size:
35.04Kb
Format:
HTML
View/Open

This item appears in the following Collection(s)

Show simple item record